Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PeproStat in open liver resection surgery
NCT02204930Phase 1Completed
- Sponsor
- Haemostatix
- Start
- Jul 2014
- Primary completion
- Sep 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of PeproStat in hemorrhage, sponsored by Haemostatix. Primary endpoint: Safety of PeproStat at 30 days. Started Jul 2014; status: completed.
02
Drugs
PeproStat
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT02204930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02204930.